Beijing, China · Founded 2016 · Privately Held (backing)
Operator of an innovative pharmaceutical company intended to be specialized in innovative drug research, clinically valuable generic drug development and pharmaceutical industrialization. PrimeGene (Beijing) is based in Beijing, China and was founded in 2016. Its last reported valuation was $248 million in Jan 2025. It has raised $85.6 million.
These 8 firms already write checks for companies like PrimeGene (Beijing). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.